Literature DB >> 11721978

A prospective surveillance of nosocomial respiratory syncytial virus infection in a hematology ward: a single-center experience in Japan.

M Kami, Y Kishi, T Hamaki, Y Maruta, E Kusumi, H Iwata, J I Ueyama, S Miyakoshi, S I Morinaga, Y Mutou.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11721978     DOI： 10.1007/bf02982076

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

1.  An outbreak of respiratory syncytial virus in a bone marrow transplant center.

Authors:  R D Harrington; T M Hooton; R C Hackman; G A Storch; B Osborne; C A Gleaves; A Benson; J D Meyers
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

2.  Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.

Authors:  E Whimbey; R E Champlin; R B Couch; J A Englund; J M Goodrich; I Raad; D Przepiorka; V A Lewis; N Mirza; H Yousuf; J J Tarrand; G P Bodey
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

3.  Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients.

Authors:  R Garcia; I Raad; D Abi-Said; G Bodey; R Champlin; J Tarrand; L A Hill; J Umphrey; J Neumann; J Englund; E Whimbey
Journal:  Infect Control Hosp Epidemiol       Date:  1997-06       Impact factor: 3.254

4.  The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.

Authors:  A J McCarthy; H M Kingman; C Kelly; G S Taylor; E O Caul; D Grier; J Moppett; A B Foot; J M Cornish; A Oakhill; C G Steward; D H Pamphilon; D I Marks
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

5.  [Epidemiological study of the prevalence of influenza in Japan--regional differences in terms of three indices (development of epidemic outbreak, viral isolation, peak of prevalence)].

Authors:  K Satsuta
Journal:  Kansenshogaku Zasshi       Date:  1994-12

6.  Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation.

Authors:  Y Kishi; M Kami; Y Oki; Y Kazuyama; M Kawabata; S Miyakoshi; S Morinaga; R Suzuki; S Mori; Y Muto
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

7.  Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission.

Authors:  K Krasinski; R LaCouture; R S Holzman; E Waithe; S Bonk; B Hanna
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

Review 8.  Respiratory syncytial virus.

Authors:  M B Filippell; T Rearick
Journal:  Nurs Clin North Am       Date:  1993-09       Impact factor: 1.208

9.  The role of respiratory syncytial virus in acute bronchiolitis in small children in northern Japan.

Authors:  M Saijo; S Takahashi; M Kokubo; T Saino; F In-Yaku; T Ishii; M Takimoto; Y Takahashi
Journal:  Acta Paediatr Jpn       Date:  1994-08

10.  Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.

Authors:  E Whimbey; R E Champlin; J A Englund; N Q Mirza; P A Piedra; J M Goodrich; D Przepiorka; M A Luna; R C Morice; J L Neumann
Journal:  Bone Marrow Transplant       Date:  1995-09       Impact factor: 5.483
View more
  2 in total

1.  Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  Takehiko Mori; Yukinori Nakamura; Jun Kato; Akiko Yamane; Yoshinobu Aisa; Kei Takeshita; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

Review 2.  Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Authors:  Fareed Khawaja; Roy F Chemaly
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.